Auctus Fund LLC 13D/13G Filings for Zevra Therapeutics, Inc. (ZVRA)

Auctus Fund LLC 13D and 13G filings for Zevra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-12
2:23 pm
Sale		2021-02-0813GZevra Therapeutics, Inc.
ZVRA		Auctus Fund LLC450,000
2.380%		-550,000decrease
(-55.00%)		Filing
2021-02-05
2:04 pm
Purchase		2021-01-2613GZevra Therapeutics, Inc.
ZVRA		Auctus Fund LLC1,000,000
8.580%		1,000,000increase
(New Position)		Filing